IL10 and diffuse large B-cell lymphoma: Similarly, levels of the anti-inflammatory cytokine IL-10 were very much higher in this cohort (elevated in all patients, median 184.5 pg/ml) as compared to that described in patients with DLBCL in Europe and the United States of America (USA) (ranging from 4.9-35 pg/ml) (Lech-Maranda et al., 2006; Načinović-Duletić et al., 2008; Gupta et al., 2012), with many patients in studies from other parts of the world having undetectable IL-10 levels.